THE EFFICACY OF INDUCTION TREATMENT WITH GUSELKUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 QUASAR INDUCTION STUDY RESULTS AT WEEK 12 BY PRIOR ADVANCED THERAPY HISTORY

Brian Bressler  ¹     Laurent Peyrin-Biroulet  ²     Jessica Allegretti  ³     Gary KH Huang  ⁴     Matthew Germinaro  ⁴     Nicole Shipitofsky  ⁴     Ye Miao  ⁴     Hongyan Zhang  ⁴     Martin Bortlík  ⁵     Tibor Hlavaty  ⁶     Toshimitsu Fujii  ⁷     Brian G. Feagan  ⁸     Bruce E. Sands  ⁹     Axel Dignass  ^10    
1 University of British Columbia, Vancouver, Canada
² Nancy University Hospital, Université de Lorraine, Nancy, France
³ Brigham and Women´s Hospital, Boston, United States
⁴ Janssen Research & Development, LLC, Spring House, United States
⁵ Nemocnice České Budějovice, Ceske Budejovice, Czechia
⁶ Cliniq s.r.o, Bratislava, Slovakia
⁷ Tokyo Medical and Dental University Hospital, Tokyo, Japan
⁸ Alimentiv Inc, London, Canada
⁹ Icahn School of Medicine at Mount Sinai, New York, United States
¹⁰ Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany

Topic
Endoscopy, IBD

Session
IL-23-Blockers in IBD: Part 1

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)